Emergence and spread of a humantransmissible multidrug-resistant nontuberculous mycobacterium
Version 2 2024-06-06, 12:42Version 2 2024-06-06, 12:42
Version 1 2022-03-21, 09:01Version 1 2022-03-21, 09:01
journal contribution
posted on 2024-06-06, 12:42authored byJM Bryant, DM Grogono, D Rodriguez-Rincon, I Everall, KP Brown, P Moreno, D Verma, E Hill, J Drijkoningen, P Gilligan, CR Esther, PG Noone, O Giddings, SC Bell, R Thomson, CE Wainwright, C Coulter, S Pandey, ME Wood, RE Stockwell, KA Ramsay, LJ Sherrard, TJ Kidd, N Jabbour, GR Johnson, LD Knibbs, L Morawska, PD Sly, A Jones, D Bilton, I Laurenson, M Ruddy, S Bourke, ICJW Bowler, SJ Chapman, A Clayton, M Cullen, O Dempsey, M Denton, M Desai, RJ Drew, F Edenborough, J Evans, J Folb, T Daniels, H Humphrey, B Isalska, S Jensen-Fangel, B Jönsson, AM Jones, TL Katzenstein, T Lillebaek, G MacGregor, S Mayell, M Millar, D Modha, EF Nash, C O'Brien, D O'Brien, C Ohri, CS Pao, D Peckham, F Perrin, A Perry, T Pressler, L Prtak, T Qvist, A Robb, H Rodgers, K Schaffer, N Shafi, J Van Ingen, M Walshaw, D Watson, N West, J Whitehouse, CS Haworth, SR Harris, D Ordway, J Parkhill, R Andres Floto
Global spread of aggressive mycobacteria
Many mycobacteria, in addition to those causing leprosy and tuberculosis, are capable of infecting humans. Some can be particularly dangerous in patients suffering from immunosuppression or chronic disease, such as cystic fibrosis (CF). Bryant
et al.
observed clusters of near-identical isolates of drug-resistant
Mycobacterium abscessus
in patients reporting to CF clinics. The similarity of the isolates suggests transmission between patients, rather than environmental acquisition. Although this bacterium is renowned for its environmental resilience, the mechanism for its long-distance transmission among the global CF patient community remains a puzzle.
Science
, this issue p.
751